These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


350 related items for PubMed ID: 6425916

  • 1. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland OK.
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH.
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [Abstract] [Full Text] [Related]

  • 3. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB, Laird LK, Morton WA, Steele TE, Kellner C, Laraia MT, Ballenger JC.
    Psychopharmacol Bull; 1989 May; 25(1):68-70. PubMed ID: 2505304
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 5. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P.
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
    Mullin JM, Pandita-Gunawardena VR, Whitehead AM.
    Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
    [No Abstract] [Full Text] [Related]

  • 7. Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo.
    Cassano GB, Conti L, Massimetti G, Mengali F, Waekelin JS, Levine J.
    Psychopharmacol Bull; 1986 Feb; 22(1):52-8. PubMed ID: 3088668
    [No Abstract] [Full Text] [Related]

  • 8. Fluvoxamine and imipramine: results of a long-term controlled trial.
    Guelfi JD, Dreyfus JF, Pichot P.
    Int Clin Psychopharmacol; 1987 Apr; 2(2):103-9. PubMed ID: 3110264
    [Abstract] [Full Text] [Related]

  • 9. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD, Dreyfus JF, Pichot P.
    Br J Clin Pharmacol; 1983 Apr; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR, Sireling LI, Bhat AV, Rao B, Paykel ES.
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [Abstract] [Full Text] [Related]

  • 11. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N, Ravic M, Bizière K.
    Drugs Exp Clin Res; 1987 Dec; 13(7):435-42. PubMed ID: 3308390
    [Abstract] [Full Text] [Related]

  • 12. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernández M, Schöny W, Schratzer M, Soukop W.
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [Abstract] [Full Text] [Related]

  • 13. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM, Shrivastava RK, Mukherjee S, Coleman BS, Michael ST.
    Br J Clin Pharmacol; 1983 Jul; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    Tijdschr Psychiatr; 2006 Jul; 48(4):271-81. PubMed ID: 16955991
    [Abstract] [Full Text] [Related]

  • 15. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS.
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [Abstract] [Full Text] [Related]

  • 16. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K, Wykoff W, Tynes LL, Schneider L, Zemansky M.
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [Abstract] [Full Text] [Related]

  • 17. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
    Gonella G, Baignoli G, Ecari U.
    Curr Med Res Opin; 1990 Sep; 12(3):177-84. PubMed ID: 2125547
    [Abstract] [Full Text] [Related]

  • 18. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL, Wakelin JS, Calanca A, Hole G.
    Adv Biochem Psychopharmacol; 1982 Sep; 32():69-75. PubMed ID: 7046368
    [No Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacology of bupropion and imipramine in elderly depressives.
    Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):130-3. PubMed ID: 6406441
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.